GLP-1 Weight Loss Injections and Testosterone in Men: Can Weight Loss Improve Low T — and When Is TRT Still Needed?

GLP-1 Weight Loss Injections and Testosterone in Men: Can Weight Loss Improve Low T — and When Is TRT Still Needed?

Many men experiencing low energy, reduced libido, poor recovery, low mood, or increasing body fat are told their symptoms are “just lifestyle” or part of getting older. In reality, excess weight and testosterone levels are closely linked, and this relationship is often misunderstood or oversimplified.

Medical weight loss — including GLP-1 weight-loss injections — can improve testosterone levels in some men. However, weight loss alone does not always resolve symptoms, and not all low testosterone is caused by obesity. For many men, the question is not simply whether weight loss helps, but whether it is enough, how long improvement takes, and when testosterone replacement therapy (TRT) may still be needed.

This article explains how excess weight affects testosterone, whether GLP-1 weight-loss injections can raise low testosterone, when TRT may still be appropriate, and how these decisions are assessed and monitored in the UK.

This content is for educational purposes only. Prescription medications require medical assessment and are not advertised directly to the public.

How does excess weight affect testosterone levels?

Excess body fat increases oestrogen production, raises systemic inflammation, and disrupts hormone signalling. Together, these effects can suppress testosterone levels in men, particularly when excess weight has been present for many years.

Why does obesity lower testosterone?

Fat tissue contains an enzyme called aromatase, which converts testosterone into oestrogen. As body fat increases, aromatase activity rises, leading to greater conversion of testosterone into oestrogen and a reduction in circulating testosterone levels.

Obesity is also associated with chronic low-grade inflammation. Excess fat tissue releases inflammatory cytokines that interfere with the hypothalamic–pituitary–gonadal (HPG) axis, the hormonal system that regulates testosterone production.

Metabolic dysfunction plays an additional role. Insulin resistance, commonly seen in obesity, disrupts hormone regulation and further suppresses testosterone production.

Sleep disorders are another contributing factor. Obstructive sleep apnoea, which is more common in men with obesity, independently lowers testosterone levels by disrupting sleep architecture and overnight hormone release.

Over time, this creates a self-reinforcing cycle: low testosterone promotes fat gain and loss of muscle mass, while increasing fat further suppresses testosterone.

What is obesity-related hypogonadism?

Obesity-related hypogonadism refers to low testosterone that is primarily driven by excess body fat rather than failure of the testes themselves.

It is often classified as functional or secondary hypogonadism. In these cases, the testes are capable of producing testosterone, but the hormonal signals from the brain are disrupted by metabolic and inflammatory factors.

This differs from primary hypogonadism, where the testes cannot produce adequate testosterone due to genetic conditions, injury, infection, surgery, chemotherapy, or age-related testicular decline.

An important distinction is that obesity-related low testosterone may improve with weight loss. However, not all men with obesity have low testosterone, and not all men with obesity-related hypogonadism fully recover testosterone levels after losing weight. Individual variation is significant.

Can GLP-1 weight-loss injections improve testosterone?

Evidence suggests that significant weight loss — including weight loss achieved using GLP-1 medications — can raise testosterone levels in men with obesity-related hypogonadism.

What does the evidence show?

Weight loss achieved through various approaches, including dietary intervention, bariatric surgery, and pharmacological treatment, has been shown to improve testosterone levels in men with obesity.

Reducing body fat lowers aromatase activity and oestrogen production, allowing testosterone levels to rise. Improvements in insulin sensitivity support healthier hormone regulation, while reduced inflammation removes suppression of the HPG axis.

GLP-1 medications are effective at achieving meaningful weight loss for many individuals, often in the range of 10–20% of body weight. Early evidence suggests that testosterone improvements tend to correlate with the degree of fat loss rather than the specific medication used.

Response varies between individuals, and improvement is not guaranteed. Weight loss may improve testosterone levels without fully resolving symptoms in some men.

How much improvement can be expected?

Testosterone improvement after weight loss varies considerably between individuals.

In general, increases in testosterone are proportional to the amount of weight lost. Men with more severe obesity-related testosterone suppression may see greater relative improvements, while others experience only modest changes.

Improvements are typically gradual and align with the pace of weight loss. Some men experience biochemical improvement before noticing symptom relief, while others report symptom improvement before testosterone levels fully normalise.

A realistic expectation is improvement, not necessarily complete resolution. This is why objective hormone testing before and during treatment is essential.

You can learn more about testosterone blood testing here:
https://www.edenclinic.co.uk/initial-testosterone-blood-test-eden-clinic

When might weight loss alone not be enough?

If testosterone levels remain low despite significant weight loss, or if symptoms persist and continue to affect quality of life, further assessment is required.

This is particularly important when low testosterone has a primary cause rather than being driven primarily by excess body fat.

Understanding primary vs secondary hypogonadism

Primary hypogonadism occurs when the testes themselves are not functioning properly. Causes include genetic conditions, testicular injury, infection, surgery, chemotherapy, or age-related testicular failure. Weight loss does not address these underlying causes.

In primary hypogonadism, luteinising hormone (LH) and follicle-stimulating hormone (FSH) are typically elevated, as the body attempts to stimulate testosterone production from the testes.

Secondary or functional hypogonadism occurs when the signalling system between the brain and testes is disrupted. The testes remain capable of producing testosterone but do not receive adequate hormonal signals.

Obesity, chronic stress, sleep disorders, certain medications, and systemic illness can all contribute. In some cases, addressing these factors leads to improvement in testosterone levels.

Blood tests measuring testosterone alongside LH and FSH help distinguish between these causes and guide treatment decisions.

Signs that TRT may still be appropriate

Testosterone replacement therapy may still be appropriate when:

• Testosterone remains low despite achieving significant weight loss
• Symptoms persist or significantly affect daily functioning
• Primary hypogonadism is identified through testing
• Weight loss is not achievable or sustainable due to other health factors

In some cases, a combined approach may be considered, using GLP-1 treatment to support metabolic health and TRT to address hormone deficiency.

You can read more about TRT options here:
https://www.edenclinic.co.uk/testosterone-replacement-therapy-trt

Can GLP-1 medications and TRT be used together?

Some men use both GLP-1 injections and TRT under medical supervision. This approach addresses metabolic health and hormone deficiency simultaneously rather than treating them in isolation.

Why might combination therapy be considered?

Combination therapy may be considered when a man has obesity alongside confirmed low testosterone that is not solely weight-related.

Severe symptoms may warrant hormone treatment while weight loss is ongoing. The metabolic benefits of GLP-1 medications can complement hormone optimisation, and successful weight loss may later allow TRT dose reassessment.

Each treatment addresses different aspects of health and should be managed together with regular review.

What needs to be monitored?

When using GLP-1 medications, TRT, or both, monitoring typically includes:

• Testosterone and full hormone panels
• Haematocrit and haemoglobin levels
• Metabolic markers such as HbA1c, fasting glucose, and lipid profile
• Blood pressure and cardiovascular risk
• Changes in body composition, not just scale weight
• Symptom tracking for energy, mood, libido, and wellbeing

Consultation and monitoring pricing can be viewed here:
https://www.edenclinic.co.uk/pricing

What about muscle loss on GLP-1 medications?

GLP-1 weight loss typically includes some muscle loss alongside fat loss. Preserving lean mass is important, particularly for men concerned about strength, energy, and long-term metabolic health.

Why does muscle loss matter for men?

Weight loss from any method usually includes some loss of lean mass. In some individuals, GLP-1 medications may be associated with higher lean mass loss.

Muscle plays a key role in physical strength, metabolic health, insulin sensitivity, and long-term vitality. Low testosterone already makes muscle maintenance more difficult, so excessive muscle loss can undermine overall health goals.

How can muscle be preserved during GLP-1 treatment?

Strategies to preserve muscle include:

• Adequate protein intake, often around 1.2–1.6 g per kg body weight
• Regular resistance or strength training
• Gradual, sustainable weight loss rather than rapid loss
• Monitoring body composition rather than focusing only on scale weight
• Clinical oversight to adjust treatment if excessive muscle loss occurs

In men receiving TRT, testosterone may help protect muscle during weight loss when appropriately indicated.

What does the UK assessment pathway look like?

A proper assessment includes baseline blood tests, evaluation of symptoms, discussion of weight and metabolic health, and a clear plan for monitoring progress.

From symptoms to treatment: the UK pathway

First, recognise the connection between weight, symptoms, and testosterone. Common symptoms include fatigue, low libido, low mood, reduced muscle mass, and poor recovery. Metabolic symptoms such as energy crashes or blood sugar instability may also be present.

Next, comprehensive baseline testing is performed. This typically includes total and free testosterone, SHBG, LH, FSH, oestradiol, metabolic markers, and general health blood tests. Testing is usually carried out in the morning while fasted.

Results are reviewed with a clinician to determine whether testosterone is genuinely low, whether the cause is likely obesity-related or primary, and how symptoms are affecting quality of life.

A treatment plan is then agreed. This may involve weight management first, TRT, a combined approach, and lifestyle support such as nutrition, exercise, sleep, and stress management.

Ongoing monitoring follows, with repeat blood tests and symptom tracking to guide adjustments and ensure long-term safety.

You can book an assessment here:
https://www.edenclinic.co.uk/main-booking-page

When should I speak to a clinician?

You should speak to a clinician before starting any treatment, if symptoms persist despite intervention, or if you experience concerning side effects.

Before starting GLP-1 medications

GLP-1 medications are prescription-only in the UK and require medical assessment. Contraindications include a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or previous pancreatitis.

Other medications and underlying health conditions must be reviewed to ensure treatment is appropriate.

Warning signs to report

Seek medical advice if you experience:

• Severe or persistent nausea or vomiting
• Severe abdominal pain, particularly if radiating to the back
• Gallbladder-type pain under the right ribs
• Rapid heart rate or palpitations
• Symptoms of low blood sugar if diabetic
• Mood or psychological changes
• Any symptom that causes concern

When to reassess your treatment plan

Reassessment is important if symptoms do not improve after sufficient time, side effects affect quality of life, weight loss plateaus, health status changes, or long-term goals shift.

Fertility considerations should also be discussed where relevant.

Key takeaways — GLP-1 injections and testosterone

GLP-1-mediated weight loss can improve obesity-related low testosterone, but some men still need TRT. Proper testing and monitoring guide the right approach.

• Excess body fat suppresses testosterone through multiple mechanisms
• Significant weight loss can raise testosterone levels in some men
• Improvement varies — some men fully recover, others partially improve
• Weight loss does not resolve primary hypogonadism
• Combination therapy may be appropriate under supervision
• Muscle preservation requires attention to protein, training, and monitoring
• Blood testing and clinician-led care support safe decisions

Learn more about testosterone replacement therapy here:
https://www.edenclinic.co.uk/testosterone-replacement-therapy-trt

‍